Cargando…

Low raltegravir transfer into the breastmilk of a woman living with HIV

Detalles Bibliográficos
Autores principales:	Feiterna-Sperling, Cornelia, Bukkems, Vera E., Teulen, Marga J.A., Colbers, Angela P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635245/ https://www.ncbi.nlm.nih.gov/pubmed/32675580 http://dx.doi.org/10.1097/QAD.0000000000002624

Ejemplares similares

Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman
por: Feiterna-Sperling, Cornelia, et al.
Publicado: (2019)

A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV
por: Bukkems, Vera E., et al.
Publicado: (2021)

Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?
por: Bukkems, Vera E., et al.
Publicado: (2020)

Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure
por: Jacobs, Tom G., et al.
Publicado: (2022)

Marketing of breastmilk substitutes during the COVID-19 pandemic
por: van Tulleken, Christoffer, et al.
Publicado: (2020)

Detection of SARS-CoV-2 in human breastmilk
por: Groß, Rüdiger, et al.
Publicado: (2020)

HIV resistance to raltegravir
por: Clavel, François
Publicado: (2009)

Raltegravir in the management of HIV-infected patients
por: Stellbrink, Hans-Jürgen
Publicado: (2009)

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network
por: Bukkems, Vera, et al.
Publicado: (2020)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Raltegravir: first in class HIV integrase inhibitor
por: Temesgen, Zelalem, et al.
Publicado: (2008)

Role of raltegravir in the management of HIV-1 infection
por: Okeke, N Lance, et al.
Publicado: (2011)

Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases
por: LaHue, Sara C., et al.
Publicado: (2020)

Raltegravir monohydrate
por: Yamuna, Thammarse S., et al.
Publicado: (2013)

Micronucleated Erythrocytes in Newborn Rats Exposed to Raltegravir Placental Transfer
por: Torres-Mendoza, Blanca Miriam, et al.
Publicado: (2014)

Breastmilk Cell and Fat Contents Respond Similarly to Removal of Breastmilk by the Infant
por: Hassiotou, Foteini, et al.
Publicado: (2013)

Duration of breastmilk feeding of NICU graduates who live with individuals who smoke
por: Northrup, Thomas F., et al.
Publicado: (2020)

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
por: Puthanakit, Thanyawee, et al.
Publicado: (2018)

Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium
por: Patten, Gabriela, et al.
Publicado: (2020)

Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review
por: Townsend, Claire L., et al.
Publicado: (2022)

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
por: Bercoff, Danielle Perez, et al.
Publicado: (2010)

Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
por: Yilmaz, Aylin, et al.
Publicado: (2009)

Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2022)

Mediastinal mass in an tuberculosis-exposed 2-year old child with neurofibromatosis type 1 – TB or not TB?
por: Krüger, Renate, et al.
Publicado: (2020)

Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
por: Chirch, Lisa M, et al.
Publicado: (2010)

Raltegravir: The evidence of its therapeutic value in HIV-1 infection
por: Ramkumar, Kavya, et al.
Publicado: (2010)

Long-term efficacy and safety of raltegravir in the management of HIV infection
por: Liedtke, Michelle D, et al.
Publicado: (2014)

Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network( )
por: Bukkems, Vera E, et al.
Publicado: (2021)

High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil
por: Pena, N Mantovani, et al.
Publicado: (2010)

Dual therapy with raltegravir plus a fixed dose combination of darunavir/ritonavir in people living with HIV in Argentina
por: Rombini, Fernanda, et al.
Publicado: (2020)

Pilot study to identify missed opportunities for prevention of childhood tuberculosis
por: Feiterna-Sperling, Cornelia, et al.
Publicado: (2022)

Correction to: Pilot study to identify missed opportunities for prevention of childhood tuberculosis
por: Feiterna-Sperling, Cornelia, et al.
Publicado: (2022)

Breastmilk or infant formula? Content analysis of infant feeding advice on breastmilk substitute manufacturer websites
por: Pomeranz, Jennifer L, et al.
Publicado: (2023)

Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting
por: Chehadeh, Wassim, et al.
Publicado: (2020)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

Raltegravir in treatment naïve patients
por: Cossarini, F, et al.
Publicado: (2009)

Raltegravir use in special populations
por: Johnson, Margaret
Publicado: (2009)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection
por: Pullen, Krista M., et al.
Publicado: (2021)

Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy
por: Charpentier, Charlotte, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4ukrpq8f6g0p1le9s2ip9ihfrd